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ABSTRACT
In archaeal rRNAs, the isomerization of uridine into
pseudouridine (C) is achieved by the H/ACA sRNPs
and the minimal set of proteins required for RNA:
C-synthase activity is the aCBF5–aNOP10 protein
pair. The crystal structure of the aCBF5–aNOP10
heterodimer from Pyrococcus abyssi was solved at
2.1 A ˚ resolution. In this structure, protein aNOP10
has an extended shape, with a zinc-binding motif at
the N-terminus and an a-helix at the C-terminus. Both
motifs contact the aCBF5 catalytic domain. Although
less efficiently as does the full-length aNOP10, the
aNOP10 C-terminal domain binds aCBF5 and sti-
mulates the RNA-guided activity. We show that the
C-terminal domain of aCBF5 (the PUA domain),
which is wrapped by an N-terminal extension of
aCBF5, plays a crucial role for aCBF5 binding to
the guide sRNA. Addition of this domain in trans
partially complement particles assembled with an
aCBF5DPUA truncated protein. In the crystal struc-
ture, the aCBF5–aNOP10 complex forms two kinds
of heterotetramers with parallel and perpendicular
orientations of the aNOP10 terminal a-helices,
respectively. By gel filtration assay, we showed that
aNOP10 can dimerize in solution. As both residues
Y41 and L48 were needed for dimerization, the
dimerization likely takes place by interaction of
parallel a-helices.
INTRODUCTION
Ribose 20-O-methylations and conversion of uridines into
pseudouridines (Y) are the two most frequent post-
transcriptional modiﬁcations in RNAs (1,2). Several of
these modiﬁcations were found to be of functional import-
ance for RNA folding or activity (3–6). In bacteria, U to Y
conversions are catalyzed by RNA:Y-synthases consisting
of a unique polypeptide, that ensures the RNA substrate recog-
nition and provides the catalytic activity (7–9). In archaea
and eukarya, the pseudouridylation and 20-O-methylation
reactions can be catalyzed by ribonucleoprotein particles
(denoted snoRNPs in eukarya and sRNPs in archaea)
[for review, (10,11)]. They consist of a guide RNA (C/D
box RNAs for 20-O-methylation and H/ACA box RNAs for
pseudouridylation) and a set of 4 to 5 proteins. Recent recon-
stitution experiments demonstrated the involvement of pro-
teins L7Ae, aCBF5, aNOP10 and aGAR1 in formation of
fully active archaeal H/ACA sRNPs (12,13). This revealed
a high degree of conservation between archaeal H/ACA
sRNPs and eukaryal H/ACA snoRNPs. Indeed, eukaryal
snoRNPs contain a set of proteins (Nhp2p, Cbf5p/Dyskerin,
Nop10p and Gar1p) very similar to that of archaeal H/ACA
sRNPs (14–16).
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formed by the guide RNAs and the target RNAs deﬁne the
positions to be modiﬁed [reviewed in (10,11)]. The H/ACA
pseudouridylation guides have highly conserved character-
istic features. As well in archaea, as in eukarya, they contain
characteristic stem–loop structures with an internal loop that is
complementary to the target RNA (17,18). This stem–loop
structure is always ﬂanked by an ANA trinucleotide (more
generally ACA). The ACA trinucleotide of archaea H/ACA
sRNAs is required for H/ACA sRNPs assembly (12,13). It
is needed to recruit protein aCBF5 carrying the conserved
motifs I and II found in bacterial RNA:Y-synthases. The
amounts of aCBF5–sRNA complexes formed by Baker
et al. (12) were much higher as the ones obtained in our
previous study (13). We do not know whether this difference
is due to the use by Baker et al. (12) of a Pyrococcus furiosus
aCBF5 protein carrying an additional His-tag sequence,
and/or to peculiar properties of the modiﬁed P.furiosus
H/ACA sRNA that was used by these authors. Binding of
protein aCBF5 to the guide sRNA is required for recruitment
of protein aNOP10 in the RNP (12,13). We showed that
this pair of proteins is the minimal set of proteins required
to get an RNA guided RNA:Y-synthase activity (13). Indeed,
using an in vitro transcribed H/ACA sRNA, an RNA sub-
strate, and the recombinant proteins aNOP10 and aCBF5,
we were able to reconstitute particles that catalyzed U to Y
conversion at the expected position in the RNA substrate (13).
This was at low yields, and addition of the L7Ae and
aGAR1 recombinant proteins led to the reconstitution of a
fully active H/ACA sRNP (more active than the one obtained
by Baker et al. (12), this may be due to the presence of His-
tags in all the proteins used by these authors). In spite of the
presence of the conserved RNA:Y-synthase motifs I and II
in protein aCBF5, this protein has no detectable
RNA:Y-synthase activity alone (13). Thus, association of
aCBF5 with aNOP10 and the H/ACA guide sRNA is required
to stimulate the aCBF5 activity. It was thus of high importance
to understand how binding of aNOP10 to aCBF5 may
contribute to the aCBF5 activation. As we showed that the
aCBF5 and aNOP10 proteins were able to interact together
and to form a stable complex in the absence of the guide RNA,
we crystallized this complex and solved its 3D structure by
X-ray crystallography. The archaeal aCBF5 enzymes share
sequence similarity with the bacterial TruB RNA:Y-synthase,
which is involved in Y55 formation in all bacterial tRNAs
(19). The 3D structure of the unbound Escherichia coli TruB
(ecTruB) protein has been solved (20), as well as, those of
the E.coli and Thermotoga maritima TruB (tmTruB) proteins
bound to a tRNA fragment (20,21). Thus, we compared
these various structures to that established for the aNOP10–
aCBF5 complex. Finally, based on the established aCBF5–
aNOP10 structure, we tested the functional importance of
some of the aNOP10 and aCBF5 domains by using site-
directed mutagenesis. The mutated proteins were used
for in vitro reconstitution of sRNP particles and the
RNA:Y-synthase activities of reconstituted particles were
measured. In this paper, we describe the 3D structure of
the Pyrococcus abyssi aCBF5–aNOP10 complex at 2.1 s
resolution, as well as, investigations on the functional roles
of the N- and C-terminal domains of aNOP10 and the
C-terminal domain of aCBF5.
MATERIALS AND METHODS
Oligonucleotides
Fragments of the aNOP10 and aCBF5 oral reading frames
(ORFs) were obtained by PCR ampliﬁcation with pairs of pri-
mers containing some of the primers already described (13).
For fragment aNOP10-Nt production, we used the aNOP10-50
and aNOP10-Nt-30 primers (50-CTCGAGTCAGTGGGCTA-
CTTTAGTCTTTTC-30, the underlined sequence introduces
a restriction site). For production of fragment aNOP10-Ct,
the primers used were: aNOP10-Ct-50 (50-AGATCTCCAC-
CAAGGTTCTCACCCGAGGAT-30) and aNOP10-30. For
fragment aCBF5DPUA production, the ampliﬁcation was
done with primers aCBF5-50 and aCBF5DPUA-30
(50-CTCGAGTCAATGTTCAACAGCTTTCTCC-30), and
for fragment PUA production, we used primers PUA-50
(50-GGATCCTTGCCTAAGATATGGATAAAG-30)a n d
aCBF5-30. PCR ampliﬁcations were also used to generate
mutations within the aNOP10 C-terminal domain: variants
aNOP10L48A and aNOP10Y41A were obtained with the
oligonucleotide pairs 50-GGTGAATACAGAAGGAGGG-
CTAAGAGGGAACTCCTGGGA-30 and 50-TCCCAGG-
AGTTCCCTCTTAGCCCTCCTTCTGTATTCACC-30, and
50-TTCTCACCCGAGGATCCAGCTGGTGAATACAGAA-
GGAGG-30 and 50-CCTCCTTCTGTATTCACCAGCTG-
GATCCTCGGGTGAGAA-30, respectively. DNA templates
for T7 in vitro transcription of the WT Pab91 and PAb91-
mtACA sRNAs and for the RNA-S substrate were obtained
by PCR ampliﬁcation as described previously (13).
Recombinant protein production
Recombinant pGEX-6P-1 (Pharmacia) vectors producing
the full-length P.abyssi proteins L7Ae, aCBF5, aNOP10
and aGAR1 fused to glutathione S-transferase (GST) were
previously constructed (13). The DNA fragments encoding
truncated aNOP10 (aNOP10-Nt and aNOP10-Ct) and aCBF5
(aCBF5DPUA and PUA) proteins were PCR-ampliﬁed as
described above and cloned between the BamHI and XhoI
restrictionsitesofplasmidpGEX-6P-1.Theresulting plasmids
are denoted pGEX-6P1-aNOP10-Nt, pGEX-6P1-aNOP10-Ct
and pGEX-6P1-aCBF5DPUA and pGEX-6P1-PUA, respect-
ively. The recombinant GST-fusion proteins were produced
inE.coliBL21CodonPluscells(Novagen).Theywerepuriﬁed
under native conditions using Glutathione–Sepharose 4Fast
Flow (Pharmacia), and the archaeal proteins were eluted
from the beads after cleavage with the PreScission Protease
as described previously (22).
Conditions used for protein crystallization
Protein aCBF5 was mixed with protein aNOP10 at a molar
ratio of 1:1.2. Crystals of the P.abyssi aCBF5–aNOP10 com-
plex were grown by vapor phase diffusion in hanging drops.
Drops were made at 293 K by mixing 1 ml of the concentrated
proteins mixture (70 mg ml
 1) and 3 ml of a reservoir solution
containing 1 M di-potassium phosphate and 100 mM sodium
acetate at pH 5.5. Crystals were ﬂash-frozen in liquid ethane
in the mother liquor with addition of 30% (v/v) glycerol as
a cryoprotectant. The aCBF5–aNOP10 crystals were in space
group P21212 with unit-cell parameters a ¼ 136.4 s,
b ¼ 136.8 s, c ¼ 59.3 s. There was two aCBF5–aNOP10
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coefﬁcient of 3.27 s
3 Da
 1 and the solvent content is of
62.1%. Crystals of SeMet-incorporated proteins were obtained
under conditions similar to those for the wild-type complex.
Data collection and structure determination
SAD data from a (SeMet)-labeled crystal ﬂash-frozen at 100 K
were collected at the absorption peak up to 2.7 s resolution at
the BM14 beamline of the European Synchrotron Radia-
tion Facility (ESRF, Grenoble). The dataset was indexed
and scaled using HKL2000 (23). Eighteen of the 20 possible
selenium sites were found and reﬁned at 2.7 s resolution using
SOLVE (24), which produced a mean ﬁgure of merit of 0.41
and an overall score of 70. After density modiﬁcation with
RESOLVE, the mean ﬁgure of merit was of 0.73. The experi-
mental electron density map was clearly interpretable and
allowed tracing of both the aNOP10 and aCBF5 molecules,
which is consistent with the positions of all 18 selenium sites
used for phasing. The model was built using O (25) and reﬁned
by CNS (26) with the maximum likelihood target using
amplitude and experimental phase distributions.
A native dataset at 2.1 s resolution was collected at 100 K
on beamline ID14-4 at the ESRF. Data were indexed and
scaled up using XDS (27).
The initial aCBF5–aNOP10 model was improved by altern-
ating cycles of simulated annealing reﬁnement against the
native dataset using CNS (26) and manual remodeling
using O (25). The ﬁnal model was reﬁned to an Rfactor of
22.4% and an Rfree of 25.2% (Table 1) and includes residues
12–138 and 153–334 of aCBF5 (chain A), residues 12–138
and 151–334 of aCBF5 (chain C), residues 4–56 of aNOP10
(chain B and D), 5 phosphate ions, 2 zinc ions and 250 water
molecules.
Gel filtration experiments
Gel ﬁltration experiments were performed using an AKTA
explorer high-performance liquid chromatography (HPLC)
(Amersham Biosciences) system, Superdex 75 or 200 HR
columns (Amersham Biosciences) at a constant ﬂow rate
(0.5 ml/min) using 20 mM HEPES buffer (pH 7.5), 1 mM
DTT, 300 mM NaCl. Proteins were detected at 280 nm using
a dual-wavelength ultraviolet (UV) detector (260–280 nm).
SDS–PAGE gel analysis of each fraction was performed
to conﬁrm the assignments of the retention peaks. For mole-
cular mass estimation, the LMW Gel Filtration Calibration
Kit and HMW Gel Filtration Calibration Kit (Amersham Bio-
sciences) were applied to the Superdex 75 and 200 column,
respectively.
Electrophoresis mobility shift assays (EMSA)
The DNA sequence of the sRNAs Pab91-WT and Pab91-
mtACA were PCR-ampliﬁed from P.abyssi GE5 genomic
DNA, using a forward primer containing a T7 promoter (13).
These DNA fragments were used as templates for in vitro
transcription of
32P-labeled sRNAs (13). sRNP complexes
were formed as described previously (13). Brieﬂy, 50 fmol
of a labeled sRNA was mixed in buffer D [150 mM KCl,
1.5 mM MgCl2, 0.2 mM EDTA and 20 mM HEPES (pH 7.9)]
with recombinant full-length or truncated proteins (200 nM
each) and the mixture was incubated for 10 min at 65 C.
The sRNPs formed were resolved in 6% non-denaturing
polyacrylamide gels. To test for the Pab91 sRNP target
RNA association (complex CII), 2.5 pmol of the previously
described (13) RNA-S target RNA, which is complementary
to the pseudouridylation pocket of sRNA Pab91, were added
in the incubation mixture. The dried gels were analyzed with
a phosphorimager (Typhoon 9410, Amersham Biosciences)
and the amounts of radioactivity in the bands were estimated
withthe ImageQuantsoftware.Thepercentageofradioactivity
in each of the RNP band as referred to the total radioactivity
in the lane was systematically established. All the gel shift
experiments were repeated three times and representative
examples are shown in the ﬁgures.
In vitro RNA:pseudouridylation assays
The RNA:Y-synthase activities of the reconstituted sRNPs
were tested by the nearest-neighbor approach (7). Conditions
for time course analysis of the in vitro pseudouridylation
reaction are detailed in (13). Typically, 4 pmol of unlabeled
sRNA and 150 fmol of target RNA, that was labeled by
[a-
32P]CTP incorporated in the course of transcription,
were mixed at 65 C with the wild-type or variant L7Ae,
aCBF5, aNOP10 and aGAR1 proteins. Aliquots were collec-
ted at different time points and the reaction was stopped by
phenol–chloroform extraction followed by ethanol precipita-
tion. The recovered target RNAs were digested with RNase
T2. The resulting 30-mononucleotides were subjected to mon-
odimensional chromatography on thin-layer cellulose plates,
as described previously (13). The radioactivity in the bands
were quantiﬁed with a phosphorimager (Amersham Bio-
sciences) using the ImageQuant software. The amounts of
Y formation as a function of time were determined taking
into account the total number of U residues in the target RNA.
Table 1. Data collection and refinement statistics
Data collection
Datasets Native SeMet
Wavelength (A ˚) 0.9686 0.9777
Resolution (A ˚)
a 30–2.1 (2.2–2.1) 50–2.7 (2.8–2.7)
Rsym (%)
a,b 6.8 (50.8) 10.8 (41.1)
Multiplicity 7.2 12.9
I/sI
a 15.6 (4.9) 9.7 (2.1)
Completeness (%)
a 99.8 (100) 95.7 (96.9)
Refinement and model quality
Resolution (A ˚) 30–2.1
Reflections work set 62200
Reflections test set 3334
Rfactor(%)
c 22.4
Rfree(%)
d 25.2
No. of protein atoms 5777
No. of water molecules 250
R.m.s.d. bonds (A ˚) 0.006
R.m.s.d. angles ( ) 1.49
Ramachandran plot (%)
Most favored 91.7
Favored 8.0
Allowed 0
Disallowed
e 0.3
aThe number in parentheses is for the highest resolution shell.
bRsym ¼
Pi
hkl jIi
hkl hIhklij=
P
hkl jIhkljwhereiis thenumberofreflectionshkl.
cRfactor ¼
P
hkl jjFo ðhklÞj   jFo hkljj=
P
hkl jFo ðhklÞj.
dRfree was calculated using 5% of the reflections left out of refinement.
eResidue Glu94 (f ¼ 43 ; y ¼  115 ) in aCBF5 is located in the i + 1
position of a bII0 turn.
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The coordinates of the P.abyssi aCBF5–aNOP10 complex
have been deposited in the Protein Data Bank (accession
code 2AUS).
RESULTS
Crystals and structure determination
The P.abyssi proteins aCBF5 and aNOP10 were mixed at a
molar ratio of 1:1.2 and good quality crystals were obtained
(see Materials and Methods for details on crystallization
conditions and crystal analysis). The structure was solved
by single anomalous diffraction (SAD). The initial phases
were calculated to 2.7 s, by using the SAD data collected
from a selenomethionine (SeMet)-labeled crystal of the
aCBF5–aNOP10 complex. Selenium was found at 18 of the
20 possible selenium sites. Phase improvement by means of
density modiﬁcation resulted in a well deﬁned electron density
map, that allowed us to build a 3D model for both the aCBF5
and aNOP10 molecules. The ﬁnal structure of the aCBF5–
aNOP10 complex was reﬁned against the dataset collected
from a native crystal to an Rfactor of 22.4% and an Rfree of
25.2%, including all reﬂections between 30 and 2.1 s resolu-
tion (Table 1). The asymmetric unit was found to contain
two aCBF5–aNOP10 complexes, 5 phosphate ions, 2 zinc
ions and 250 water molecules. Superimposition of the two
independent aCBF5–aNOP10 heterodimers in the asymmetric
unit yields a r.m.s deviation of 1.08 s for 1424 backbone
atoms. In the established structure, over 91% of the residues
are within the most favored regions in a Ramachandran plot,
as deﬁned by PROCHECK (28). Only well-ordered Glu94 of
both aCBF5 molecules have unfavorable main-chain torsion
angles (f ¼ 43 ; y ¼  115 ), but these torsion angles are
consistent with the location of Glu94 in the i + 1 position
of a bII0 turn (29,30).
Structure overview of the aCBF5–aNOP10 complex
In the crystal, the aNOP10 structure consists of a zinc-binding
motif at the N-terminal end, a linker region and a a-helix at
the C-terminal end (Figure 1A). The overall structure presents
no structural homology with previously determined protein
structures, as shown by a Dali search (http://www.ebi.ac.uk/
dali/). However, the zinc-binding motif (Figure 1B), that con-
tains a cluster of four cysteines (C8-X2-C11-X8-C20-X2-C23),
can be superimposed with a similar cluster present in the
P.abyssi factor aIF2 (residues 56–81). The deviation for
26 Ca atoms is of 0.41 s r.m.s. The aIF2 factor is the archaeal
counterpart of the eukaryotic translation initiation factor
IF2-a (19). The electron density map of aNOP10 clearly
shows the presence of a tetra-coordinated metal and a zinc
atom was detected by X-ray ﬂuorescence measurement.
Moreover, alignment of the aNOP10 sequences from various
archaeal species strongly indicates the presence of a zinc
knuckle in all members of this protein family. Furthermore,
the four cysteines are strictly conserved (Figure 1C). In con-
trast, this cysteine cluster is not found in the eukaryal Nop10
proteins (data not shown). In the crystal, each of the aNOP10
proteins are bound with one aCBF5 molecule, and two inde-
pendent aCBF5–aNOP10 heterodimers are each related to an
identical heterodimer via crystallographic 2-fold axes. They
form heterotetramers by interaction of two aNOP10 proteins
(Figure 1D and E).
The structure of aCBF5 consists of two distinct domains
(Figure 2A): a large catalytic domain and a small C-terminal
domain corresponding to a PUA domain (pseudouridine
synthase and archaeosine transglycosylase domain) (31).
The overall fold of aCBF5 is similar to that of the tmTruB
enzyme (20), with a 2.95 s r.m.s. deviation for 257 Ca
atoms (Figure 2C). Comparison of the aCBF5 and tmTruB
catalytic domains revealed two major differences: the
deletion of two sequences of 17 residues, and the insertion
of an additional a-helix (11 residues) in protein aCBF5 com-
pared to tmTruB. Interestingly, this additional a-helix is also
found in ecTruB (helix a6) (21). The two Ins1 and Ins2
sequences, which are deleted in aCBF5, are present in both
tmTruB and ecTruB and are located in the thumb-loop. These
Ins1 and Ins2 sequences are considered to be characteristic
features of the TruB RNA:Y-synthase family (21). Com-
parison of the aCBF5 and tmTruB C-terminal domains
reveals several differences. First, in aCBF5 the sequence
between the b-strands b16 and b17 is lacking 4-residues com-
pared to that in tmTruB and the resulting truncated sequence
forms an additional a-helix (a9). Secondly, seven additional
residues extend the C-terminus of aCBF5 compared to that
of tmTruB. Finally, 33 additional residues are present at the
N-terminus of aCBF5. They are wrapping the C-terminal
PUA domain and form one additional b-strand (b18), that
is located at one extremity of the b-sheet (Figure 2A). To
superimpose the C-terminal domain of aCBF5 with that of
the RNA-free ecTruB, a rigid body movement of the tip of
the C-terminal domain toward the catalytic domain of aCBF5
with a maximum displacement of 5 s is needed (Figure 2B).
Superimposition of aCBF5 with the RNA-bound ecTruB
requires a second rigid body movement of the C-terminal
domain toward the RNA of the ecTruB–RNA complex,
with a maximum displacement of 5 s at the tip of the
C-terminal domain (Figure 2C). The latter movement is
also needed to superimpose the ecTruB RNA-free form
with the RNA-bound tmTruB (20).
aCBF5, dyskerin and TruB share a common active site
The aCBF5 catalytic domain folds into an extensive b-sheet.
At one side of the faces of the sheet, a cleft is delineated
by helices a2 and a5 and loops b11-a5, b2-b3 and a2-b4.
According to previous analysis on the TruB enzyme, the active
site lies at the bottom of this cleft (21). Indeed, an aspartate
residue (Asp82 in aCBF5, Aps48 in ecTruB and Asp125 in the
human dyskerin) is conserved in all known RNA:Y-synthases
(32,33), and it was already shown to be essential for RNA:Y-
synthase activity (13), as well in the TruB enzymes (34), as in
protein aCBF5 (35).
In the TruB enzymes, two tyrosine residues (Tyr76 and
Tyr179 in ecTruB) were shown to play an important role in
orientation of the target uracil base (21). These residues are
conserved in aCBF5. In the RNA-bound ecTruB, Tyr179
stacks against the sugar of the uracil substrate, and the
aromatic ring of Tyr76 makes a stacking interaction with
the uracil base (21).Both interactions are proposed to orientate
the C6 atom towards the carboxylate of the catalytic aspartate
Nucleic Acids Research, 2006, Vol. 34, No. 3 829to favor the reaction (21). It is also proposed that Tyr179 acts
as a general base for the proton abstraction, which is required
in the last step of Y formation (36). An Arg residue (Arg181 in
ecTruB) also participates to the active site by formation of a
salt bridge and two hydrogen bonds with the catalytic Asp48
residue (21). The superimposition of the 3D structure of
the aCBF5 catalytic domain on to those of the RNA-free
and RNA-bound ecTruB structures (20) shows the presence
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Figure 1. The P.abyssi aNOP10 3D structure in aCBF5–aNOP10 crystals (A) Ribbon representation. The Zn
2+ ion detected in the crystal structure is represented
byaredball.ThearrowindicatesthepositionoftheC-terminalendtruncationintheaNOP10-Ntvariantproteinproducedinthisstudy(seeFigure4A).(B)Close-up
view of the 2Fo-Fc electron density map (blue), contoured at 1.2 s, in the region of the zinc-binding domain. The zinc atom is drawn in red. The simulated
annealingomittedFo-Fcmap(green)ofthezincioniscontouredat5s.(C) SequencealignmentsofarchaealaNOP10proteins.Residuesinvolvedintheside-chain
interactions between proteins aNOP10 and aCBF5 and in the aNOP10 homodimerization are indicated by white and black diamonds, respectively. Sequences
areretrievedfromtheSWISS-PROTdatabase.(DandE)RibbonrepresentationofthetwodistinctaCBF5–aNOP10heterotetramersformedbyaNOP10dimerization
and found in the crystal.
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Figure 2. The P.abyssi aCBF5 structure in aCBF5–aNOP10 crystals and its comparison with the E.coli and T.maritima TruB 3D structure (ecTruB and
tmTruB, respectively) (A) Ribbon representation of the established aCBF5 structure. The position of the C-terminal extremity (249) of the variant aCBF5 protein
aCBF5DPUA produced in this study is represented (see Figure 4). The N-terminal extension is drawn in yellow. (B) Superimposition of the aCBF5 3D structure
(green) with that of the free ecTruB (blue) (20). (C) Superimposition of the aCBF5 3D structure (green) with that of the RNA-bounded tmTruB (red) (20). Note
that aCBF5 is oriented differently (rotation by 90 ) in (B) and (C). (D) Superposition of the catalytic residues of protein aCBF5 (green) with the corresponding
residuesfromtheRNA-freeecTruBprotein(blue)(20)andtheRNA-associatedtmTruBprotein(red)(20).TheaCBF5aminoacidsnumberingisused.Theposition
identified for 5-fluoro-6-hydroxypseudouridine (5FhY) after catalysis by the ecTruB protein is indicated (21).
Nucleic Acids Research, 2006, Vol. 34, No. 3 831in the active site of aCBF5 of four residues (Asp82, Tyr110,
Tyr179 and Arg181, respectively), which are homologous to
the ecTruB Asp48, Tyr76, Tyr179 and Arg181 residues,
respectively. The two sets of four residues have similar loca-
tions in the active sites of both enzymes (Figure 2D). As,
the conformations of these residues are modiﬁed upon RNA
binding on the ecTruB enzyme, it was also interesting to
compare the conformations of their lateral chains in the
available 3D structures. Upon RNA binding, the Asp48 con-
formation is modiﬁed, as it forms an ionic interaction with
residue Arg181 (20). On the other hand, Tyr179 moves toward
and clamps the uracil ring into a productive orientation for
catalysis (20). Interestingly, the conformation of the catalytic
Asp82 residue in the aCBF5 structure is closer to that of the
catalytic Asp48 residue in the RNA-bound forms of ecTruB
and tmTruB, than to the one of this residue in the unbound
form of ecTruB (Figure 2D). Remarkably also, the position
of Tyr179 in aCBF5 is closer to that in the bound forms of
ecTruB and tmTruB, than to that in free ecTruB. Thus, in the
aCBF5–aNOP10complex, residues ofthe aCBF5catalyticsite
likely have a conformation, which is favorable for catalysis of
the U to Y conversion.
aNOP10 interacts with the catalytic domain of aCBF5
In the crystal structure, the aCBF5–aNOP10 interface
(1292 s
2) involves 26% of the total solvent-accessible surface
area of aNOP10 and 9% of the total solvent-accessible surface
area of aCBF5. Indeed, the surface of aNOP10 is strongly
involved in the heterodimer interface and half of this interface
is nonpolar. The side-chain interactions formed in the crystal
are both of hydrophobic and of ionic types (Figure 3). Two
distinct hydrophobic surfaces are observed at the heterodimer
interface. The ﬁrst one includes the hydrophobic residues at
the surface of the zinc-binding motif. They are involved in
formation of a hydrophobic cluster with hydrophobic residues
from the contiguous b-strands b4 and b11 of protein aCBF5.
The second hydrophobic surface involves residues on one
face of the C-terminal a-helix in protein aNOP10 and hydro-
phobic residues of the helices a1, a6 and a7 in protein
aCBF5. Besides these hydrophobic contacts, basic residues
of the C-terminal a-helix and at the surface of the zinc-
binding domain of protein aNOP10 form ionic interactions
with acidic residues in protein aCBF5. These aCBF5 residues
belong to helix a6 and to the loops located upstream of b11
and a6, respectively. Moreover, one phosphate ion is found at
the interface between proteins aNOP10 and aCBF5 and it
interacts with the side-chains of residues Arg46 and Arg50
from aNOP10 and His225 from aCBF5.
DistinctrolesoftheaNOP10N-andC-terminaldomains
In our recent study (13), we showed that a complex designated
RNP3 (Figure 4B, lane 2) is formed by direct interaction
between proteins aCBF5 and L7Ae and the Pab91 sRNA.
In the presence of protein aNOP10, complex RNP3 is con-
verted into an RNP5 complex (Figure 4B, lane 4). As pro-
tein aNOP10 did not show direct sRNA binding activity,
protein aCBF5 is proposed to drive the incorporation of
protein aNOP10 into the sRNP (12,13). In addition, protein
aNOP10 is required for incorporation of the RNA substrate
(Figure 4B, lanes 3 and 5) (13) leading to the formation of
the CII complex (marked by asterisks in Figure 4B). This
complex has a higher electrophoretic mobility compared
to complex RNP5 (Figure 4B, lanes 4 and 5). As both the
N- and C-terminal fragments of aNOP10 interact with aCBF5
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Figure 3. Interface between proteins aNOP10 and aCBF5 in the crystal
(A) Ribbon representation of the aCBF5–aNOP10 heterodimer and (B) mole-
cularsurfaceofthe aNOP10(orange)andaCBF5(green)surfacein thecrystal.
(C, D) Hydrophobic (gray), acidic (red) and basic (blue) residues at the
aCBF5–aNOP10 interfaces are represented in aCBF5 (C) and aNOP10 (D).
(E)CalculatedelectrostaticpotentialfortheaCBF5–aNOP10complexmapped
on its molecular surface. Positive and negative potential are drawn in blue and
red, respectively. (F) Ribbon representation of the aCBF5–aNOP10 complex
in the same orientation as in (E). Views in (A–C) have the same orientation;
view in (D) isrotatedby 180  and theaCBF5–aNOP10 structurein(E andF) is
rotated by 90 .
832 Nucleic Acids Research, 2006, Vol. 34, No. 3according to our 3D structure analysis, we tested whether one
of them or both are required to recruit the RNA substrate
during complex CII formation. To this end, two aNOP10 frag-
ments (aNOP10-Nt and aNOP10-Ct) were produced and puri-
ﬁed. The aNOP10-Nt fragment contained the zinc-binding
domain and the aNOP10-Ct fragment carried the 29 C-
terminal residues with the a-helix (Figure 4A). Interestingly,
the formation of an RNP5-like complex (containing proteins
L7Ae, aCBF5 and aNOP10-Nt) demonstrated the association
of fragment aNOP10-Nt with the aCBF5 protein bound to the
guide. However, no CII complex was detected, upon addition
of the RNA substrate (Figure 4B, lanes 6 and 7). On the
contrary, although no RNP5-like complex was formed upon
incubation of protein aCBF5 with the guide RNA and the
aNOP10-Ct fragment, a complex expected to correspond to
the CII complex was assembled in the presence of the RNA
substrate (Figure 4B, lanes 8 and 9). When formation of com-
plex CII was tested in the presence of the two aNOP10-Nt and
aNOP10-Ct fragments, a complex with an electrophoretic
mobility lower than that of complex CII was obtained
(Figure 4B, lane 11). The RNA:Y-synthase activity of the
reconstituted sRNPs was measured by use of the nearest-
neighbor approach described in Materials and Methods.
According to the data obtained, the aNOP10-Ct fragment
was sufﬁcient to get an active particle (Figure 4C). Indeed,
after a 80 min incubation of the guide sRNA and the RNA
substrate with the L7Ae, aCBF5, aGAR1 and aNOP10-Ct
protein set, more than 50% of the RNA substrates were
modiﬁed. In contrast, a very low activity was obtained
when using the aNOP10-Nt fragment. Hence, the
C-terminal domain of aNOP10 alone is able to stimulate
the aCBF5 activity. Nevertheless, the kinetics of the reaction
was slower as compared to that obtained for the full-
length aNOP10 protein. Surprisingly, in the presence of the
two aNOP10-Nt and aNOP10-Ct fragments, the rate of
the reaction was very low. It was similar to that found for
the aNOP10-Nt fragment alone. Thus, addition of the
aNOP10-Nt fragment counteracted the positive effect of the
aNOP10-Ct fragment. Taken together, we concluded that
the full stimulation of the aCBF5 activity requires the
aNOP10 C- and N-terminal domains and the integrity of
the linker fragment.
We then tested whether the presence of the Zn
2+ ion was
important for sRNP activity. To this end, a aNOP10C11S
variant protein lacking one of the four cysteine residues
required for Zn
2+ binding was produced. The mutation had
no effect on RNP5 and CII complex formation, and on
the catalytic property of the reconstituted particles (data
not shown). We, thus, concluded that the presence of a
Zn
2+ ion in aNOP10 is not required for RNP assembly and
activity.
The PUA domain is required for aCBF5 binding
to the sRNA
To test whether the PUA domain has a functional role in
H/ACA sRNP assembly and function or whether the aCBF5
catalytic domain is sufﬁcient for production of active sRNPs,
we produced an aCBF5DPUA protein missing the C-terminal
PUA domain (Figure 5A) and studied sRNP assembly with
this protein. As shown in Figure 5, upon incubation of the
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Figure 4. Analysis of the functional roles of the N- and C-terminal domains of
protein aNOP10. (A) Schematic representation of the aNOP10 fragments used
in this study. The four cysteine residues of the zinc finger domain of protein
aNOP10areindicated.(B)AnalysisbygelmobilityshiftassaysofcomplexCII
formation. The radio-labeled Pab91 sRNA (50 fmol) was incubated with the
L7Ae and aCBF5 proteins (200 nM each) and, as indicated on top of the lanes,
either the WT aNOP10protein (lanes 4 and 5), the Nt or Ct aNOP10 fragments
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Nucleic Acids Research, 2006, Vol. 34, No. 3 833radio-labeled sRNA Pab91 with the aCBF5DPUA and L7Ae
proteins, only the L7Ae-containing complex (RNP1) was
formed (Figure 5B, lane 4). The same result was obtained
in the presence of aNOP10 (Figure 5B, lane 5).
In addition, when the RNA substrate was added to the
incubation mixture containing the guide sRNA and the L7Ae,
aCBF5DPUA and aNOP10 protein set, the CII complex was
formed at very low yield (Figure 5C, lane 4). Accordingly,
time course analysis of the pseudouridylation reaction
revealed a very low efﬁciency of particles reconstituted
with the truncated aCBF5 protein. Only 10% of the RNA
substrate molecules were modiﬁed after a 80 min incubation
(Figure 5D). We, thus, concluded that the PUA domain has
a crucial role for aCBF5 binding to the Pab91 sRNA and as
a result for proper H/ACA sRNP assembly. Interestingly,
when the PUA domain was added in trans in the reaction
mixture, a higher amount of CII complex was formed
(Figure 5C, compare lane 6 with lane 4) and the rate of the
reaction was enhanced. After a 80 min incubation, about
70% of the RNA substrate molecules were modiﬁed
(Figure 5D). When the same assay was repeated with the
variant Pab91mtACA, containing an ACA to UGU substitu-
tion (13), the addition of the PUA domain had no positive
effect on the sRNP activity (Figure 5D). We concluded that
A
PUA aCBF5
aCBF5∆PUA
13 3 4 250
12 4 9
334 250
PUA
I II
I II
PUA
B
L7Ae
aCBF5
aCBF5∆PUA
aNOP10
-
-
-
-
+
+
-
-
+
+
-
+
+
-
+
-
+
-
+
+
RNP5
RNP1
sRNA
RNP3
RNP5
RNP3
RNP1
1    2    3    4    5
2
92
21
71 94  94 D
 
Ψ
 
(
m
o
l
.
m
o
l
-
1
)
Time (min)
0 20 40 60 80
0,0
0,2
0,4
0,6
0,8
1,0
LCNG
L∆CNG
+ PUA
L∆CNG + PUA
Pab91mtACA
L∆CNG
+
-
-
-
+L7Ae/aNOP10
1   2    3    4    5    6
aCBF5
aCBF5∆PUA
PUA
RNA substrate
RNP5
CII
RNP1
RNP5
CII
RNP1
17
71
87
9
<1
89
8
87
<1
88
23
69
C
+
-
-
+
-
+
-
-
-
+
-
+
-
+
+
-
-
+
+
+
sRNA
* * *
Figure 5. PUAtrans-complementationofthe aCBF5activity.(A) Schematicrepresentationof theaCBF5proteinwiththe N-terminalextensionfoundin the RNA-
guided Y-synthases (black box), the highly conserved motifs I and II in the catalytic domain, and the pseudouridine synthase archeosine transglycosylase domain,
PUA (white) are represented. The two aCBF5 fragments used in this study (aCBF5DPUA and PUA) are shown below. (B) Analysis by EMSA of the complexes
formedwiththeradio-labeledPab91sRNA(50fmol),proteinsL7AeandaNOP10andeitherthefull-lengthaCBF5ortheaCBF5DPUAfragment(200nMeach).The
RNPcomplexesidentifiedbyphosphorimageranalysisarenumberedaccordingto(13).Thepercentagesofradioactivityineachcomplexesascomparedtothetotal
amountsofradioactivityinthelanesaregivenbelowthelanes.(C)AnalysisbyEMSAofcomplexCIIformedwiththewild-typeorvariantaCBF5proteins.Complex
CIIformationwastestedbyincubationofthePab91sRNAwithproteinsL7AeandaNOP10(200nM)andeitherthefull-lengthaCBF5protein(lanes1and2)orthe
truncatedaCBF5DPUAprotein(200nM)(lanes3–6)in thepresence(lanes5and6)orabsence(lanes3 and4)ofthe PUAfragment (200nM).A50molarexcessof
unlabeled RNA substrate was added to the mixture (as indicated above each lane). Complexes were fractionated by gel electrophoresis. The nomenclature is
accordingto (13) and the CIIcomplexes are markedby anasterisk. Thepercentages ofPab91sRNA present in each RNPas referredto the total RNA amountin the
lane are given below the lanes. (D) Time course analyses of in vitro pseudouridylation reactions. The unlabeled WT Pab91 (filled symbols) or Pab91mtACA (open
symbols)sRNA(4 pmol)wasincubatedat65 C withthe labeledRNAsubstrate(150fmol)and variouscombinationsofthe coreproteins: L7Ae(L),aCBF5(C)or
aCBF5DPUA (DC) with or without the PUA fragment.
834 Nucleic Acids Research, 2006, Vol. 34, No. 3the PUA domain of protein aCBF5 likely interacts with the
conserved ACA sequence in the H/ACA sRNA.
The aNOP10 Tyr41 and Leu48 residues are necessary
for aNOP10 dimerization
As described above, the aCBF5–aNOP10 heterodimers were
found in two kinds of heterotetramer structures in the crystal
(Figure 1D and E). Formation of these heterotetramers relies
on aNOP10 dimerization. In one heterotetramer, the aNOP10
dimerization interface is formed of the two C-terminal
a-helices, which are parallel to each other (Figure 6A), and
the interface buries a quite large solvent-accessible surface
area of 1507 s
2. This interface involves the hydrophobic
residues Tyr41, Leu48 and Leu52, which are located on
one face of the a-helix (Figure 6C). In addition, two phosphate
ions are bound at the N-terminal end of the a-helices and
form hydrogen bonds with the Ser36 residues of both
aNOP10 molecules. In the second heterotetramer, the aNOP10
dimerization interface buries a much lower solvent-accessible
surface area (798 s
2). The two a-helices are perpendicular to
each other and only the N-terminal part of these helices are
involved in the interface (Figure 6B). The Tyr41 and Tyr44
residues from both a-helices form a small aromatic cluster
(Figure 6D) and no phosphate ion is bound unlike in the
other dimer.
Analytical gel ﬁltration analysis (Figure 6E and F) showed
that the pure aNOP10 protein migrates as two peaks
corresponding to a monomer–dimer equilibrium with a high
proportion of the monomer form. These results suggested that
in the absence of protein aCBF5, protein aNOP10 forms
homodimers in solution. When the aNOP10 and aCBF5
proteins were mixed at a 1.2:1 ratio, two main peaks were
obtained, in addition to the peak corresponding to the resi-
dual free aNOP10 protein (Figure 6E). They corresponded to
aCBF5–aNOP10 heterodimers and heterotetramer, e.g. an
heterodimer of two aCBF5–aNOP10 heterodimers. Therefore,
in accordance with the crystal structure, the aNOP10-aCBF5
heterodimers can form heterotetramers in solution, likely via
the aNOP10–aNOP10 interaction.
In order to get an idea of the kind of aNOP10
homodimers formed in solution, we produced two aNOP10
protein variants. In variant aNOP10Y41A, residue Tyr41
involved in both types of aNOP10 dimers was mutated, and
in variant aNOP10L48A we mutated residue Leu48, which is
expected to be only involved in the formation of homodimers
with two parallel helices. As shown by gel ﬁltration assays,
both amino acids substitutions abolished homodimer forma-
tion, which is in favor of the formation of homodimers with
parallel helices in solution.
DISCUSSION
As stated in the introduction, the aCBF5 RNA:Y-synthase
of archaeal H/ACA sRNPs is inactive by itself. It needs asso-
ciation with the aNOP10 protein and the H/ACA sRNA to
become active. The present study brings important information
for understanding this peculiar property of the archaeal aCBF5
enzyme. This is as much important, as the observed peculiar-
ities of aCBF5 compared to other RNA:Y synthases, are likely
shared with its eukaryotic counterparts (Cbf5p/Dyskerin).
Similarities and differences between the aCBF5
and TruB 3D structures
As the TruB enzyme, protein aCBF5 consists of a large
catalytic domain and a small C-terminal PUA domain. How-
ever, one important difference between aCBF5 and TruB is
the presence of a 33 residues additional N-terminal sequence
that wraps the PUA domain. This additional sequence is
found in all the characterized archaeal aCBF5 enzymes and
is also present in their eukaryal counterparts. To test for its
function we tried to produce an aCBF5 protein truncated of
this N-terminal additional sequence. This was not possible
because the truncated protein turned to be unstable when pro-
duced in E.coli. Hence, we concluded that the 33 N-terminal
residues of the P.abyssi aCBF5 protein are important for the
correct folding and/or the stability of the enzyme. Wrapping of
the PUA domain by the N-terminus may also be important
for its precise positioning relative to the catalytic domain.
This may be as much important as our data demonstrate a
role of the PUA domain in aCBF5 binding to the sRNA.
Previous (12,13) and present results strongly support the
idea that aCBF5 association with the guide sRNA depends
upon the ACA conserved motif of H/ACA sRNAs.
Interestingly, the PUA domain was originally found in the
archeosine tRNA-guanine transglycosylase (ArcTGT) (31),
that modiﬁes G15 of the D-arm of tRNA (37,38). The 3D
structure analysis of a tRNA bound ArcTGT revealed the
interactions of the PUA domain with the acceptor stem and
the CCA terminus of the tRNA (39). In addition, in TruB, the
PUA domain is also expected to interact with the tRNA
acceptor arm (40). Although the observed interactions essen-
tially concern the backbone of the RNA, PUA domains seem
to develop preferential interactions with NCA trinucleotide
sequences (21). The ACA trinucleotide in H/ACA sRNAs
is located at a constant distance of the targeted uridine
in the sRNA–target RNA complex (14 to 16 bp ﬂanked
by the ACA motif) [(41) and S. Muller, F. Leclerc and
C. Branlant, unpublished data]. This constant distance may
represent a key determinant for a good positioning of the
targeted uridine in the active site.
Concerning RNA binding, it is interesting to note that
because the aCBF5–aNOP10 interaction masks the negative
charges present on the surface of protein aCBF5, the surface
formed by association of proteins aCBF5 and aNOP10 is
mostly positively charged (Figure 3E). This surface electro-
static potential is highly favorable for a large interaction
with the guide RNA and the RNA substrate. Hence, masking
negative charges on the aCBF5 surface may be one of the
multiple roles played by protein aNOP10. It might also be
that the aNOP10 interaction in the aCBF5–aNOP10 complex
is responsible for the difference of conformation of residues
Tyr179 and Asp82 in the active site, as compared to those of
their counterpartsintheRNA-freeecTruBenzyme(20).Based
on the observed conformation of these two residues in the
aCBF5–aNOP10 complex, a more limited induced ﬁt should
be needed for substrate binding, as compared to the ecTRuB
enzyme. This may explain our previous observation of a
high catalytic efﬁciency of the Pab91 reconstituted sRNP
when the small RNA-S substrate was used (100% of RNA
modiﬁcation after a 5 min incubation of the RNA–protein
mixture) (13).
Nucleic Acids Research, 2006, Vol. 34, No. 3 835The numerous interactions between aCBF5 and
aNOP10 play differential roles in aCBF5 activation
Our crystal structure reveals a very elongate shape of
protein aNOP10. This very elongated shape allows the
interaction of protein aNOP10 with the two lobs of the
aCBF5 catalytic domain. Such an elongated shape was already
found for several ribosomal proteins (42). In spite that both
the N- and C-terminal domains of protein aNOP10 can form
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Figure 6. Analysis of protein aNOP10 dimerization by gel filtration (A, B, C and D) Ribbon representation of the two distinct aNOP10 dimers (A) and (B) found
in the crystal structure and their corresponding close-up views (C) and (D). (E) Dimer formation analysis by gel filtration. The purified aNOP10 protein and
aCBF5proteinalone,oramixtureofthesetwoproteinsina1.2:1molarratiowereincubatedasdescribedinMaterialsandMethodsandwereanalyzedbygelfiltration
onaSuperdex200.Theelutionprofilesarerepresentedinorange,greenandblue,respectively.Theinsetrepresentstheelutiontimesofstandardmolecularmarkersas
a function of the log of theirmolecular weights(Da): bovin gammaglobulin(158000 Da), BSA (67000 Da), chickenovalbumin(43000 Da), chymotrypsinogenA
(25000), equine myoglobin (17500 Da), Ribonuclease A (13700) and Vitamin B12 (1350 Da). (F) Effects of the Y41A and L48A amino acids substitutions in
aNOP10onthedimerizationproperties.FractionationwasperformedonaSuperdex75column.TheelutionprofilesoftheWT,L48AandY41Avariantproteinsare
drawnin red,greenandblue,respectively. Theinsetrepresentselutiontimes ofstandardmolecularmarkersasa functionof thelogoftheirmolecularweights(Da):
chicken ovalbumin (43000 Da), chymotrypsinogen A (25000) and Ribonuclease A (13700).
836 Nucleic Acids Research, 2006, Vol. 34, No. 3ionic and hydrophobic interactions with aCBF5 (Figure 3),
the C-terminal part of protein aNOP10 does not form a
stable complex with protein aCBF5 bound to the sRNA
(Figure 4B). For integration in the RNP complex the
aNOP10 C-terminal domain needs the presence of the RNA
substrate and particles reconstituted with this fragment are
active (60% of the WT activity with a lag period in the
kinetics) (Figure 4C). In contrast, the aNOP10 N-terminal
domain that contains the Zn
2+ binding domain has the capab-
ility to bind protein aCBF5, however, active particles are not
generated with this domain (Figure 4B and C). In addition,
mutation of one of the four cysteines (C11) of the Zn
2+ binding
site had no effect on the RNA:Y-synthase activity. This is
in contrast to ﬁnding of a requirement of Zn
2+ ions for
activity of the Saccharomyces cerevisiae Pus1p RNA:Y-
synthase (43). The present data show that the aNOP10 Zn
2+
ion is not essential for sRNP activity. However, the
aNOP10 N-terminal domain may reinforce the sRNP activity
by: (i) a role in anchoring the aNOP10 protein on to the
aCBF5 protein, (ii) modifying the conformation of the
aCBF5 active site and/or (iii) remodeling the structure of
the guide RNA, as very recent proposed for the eukaryal
Nop10 protein (44). Indeed, after submission of this article,
an NMR spectroscopy study of the interaction between the
yeast Nop10p protein and one stem–loop structure of a human
H/ACA snoRNA was published by the J. Feigon’s laboratory
(44). The authors propose that the folded N-terminal region
of Nop10p interacts weakly with the snoRNA, in the region
at the junction between the lower stem and the pseudouri-
dylation pocket. As the pseudouridylation pocket is partially
structured in absence of proteins (44), such an interaction may
participate in the opening of the pseudouridylation pocket to
favor duplex formation between the guide and the substrate
RNAs. In light of this hypothesis, it will be interesting to
test whether the lower sRNP activity, that we observed
when using the aNOP10 C-terminal domain as compared to
the full-length aNOP10 protein, is in part due to the absence
of remodeling of the guide RNA structure by the aNOP10
N-terminal domain. Indeed, in the absence of the aNOP10
N-terminal domain, only 60% of the RNA substrate molecules
were modiﬁed and a lag period was observed in the kinetics
of the reaction (Figure 4C).
As the RNA-duplex formed by the guide RNA and
the RNA substrate is able to generate a stable interaction
between protein aCBF5 and the aNOP10 C-terminal
domain, leading to a functional particle, we conclude that
this RNA duplex is able to supply, at least partially, for the
absence of the anchoring aNOP10 N-terminal domain.
Surprisingly, no sRNP activity was observed when the
C- and N-terminal domains of protein aNOP10 were present
together as separate entities. Several explanations can be
proposed for this observation. First, an aberrant structure
may be formed by interaction of the two halves of
aNOP10. Secondly, the aNOP10 N-terminal domain may
interact with both lobs of the aCBF5 catalytic domain, thus,
avoiding the binding of the aNOP10 C-terminal domain.
Finally, and more simply there may be a negative effect of
the charged carboxylate at the extremity of the aNOP10
N-terminal domain. It may interfere with the aCBF5 active
site, for instance by formation of an ion pair with the catalytic
Asp82 residue.
Is the aNOP10 dimerization of functional importance?
Surprisingly, our crystals contained two kinds of aNOP10
dimers (Figure 1D and E; Figure 6). This suggests that the
two kinds of dimers may exist in equilibrium in solution.
However, according to our site-directed mutagenesis ana-
lysis only dimers with parallel a-helices are stable in solution.
Interestingly, in the crystal, these dimers with parallel a-
helices contained two phosphate ions hydrogen-bonded with
residue S36. This opens the question of a possible involvement
of dimer formation in RNA binding. As no phosphate ion
was found in the dimers with perpendicular helices, the
involvement of a conformational transition from one dimer
conformation to the other one may participate to the dis-
sociation of the modiﬁed substrate RNA.
During the time that this paper was evaluated, the 3D struc-
tures of the aCBF5–aNOP10 complex from Methanococcus
jannaschii, and of the Nop10 proteins from S.cerevisiae
and M.jannaschii have been solved (44,45). Our data on the
P.abyssi aCBF5–aNOP10 complex are in perfect agreement
with those obtained for the M.jannaschii complex. Moreover,
our data reinforce the idea that the C-terminal a-helix of
aNOP10 is stabilized upon interaction with aCBF5 (45). By
inspection of the data obtained by Hamma et al. (45) for the
M.jannaschii aCBF5–aNOP10 complex (PDB ID 2apo), we
observed that the asymmetric unit contains only one hetero-
dimer that is related to an identical heterodimer via a crystal-
lographic 2-fold axis. Interestingly, the quaternary structure
for the heterotetramer found in their crystal corresponds to the
P.abyssi heterotetramer in which the two aNOP10 a-helices
are perpendicular to each other. In the M.jannaschii quater-
nary structure, the aromatic cluster located at the interface of
the aNOP10 helices is formed by the Trp42 and Tyr45
residues, corresponding to the Tyr41 and Tyr44 residues
found in the P.abyssi aNOP10 cluster (Figure 1C). Thus,
both the P.abyssi and the P.jannaschii aCBF5–aNOP10
complexes are found as heterotetramers in crystal structures.
In connection with a possible role of these aCBF5–aNOP10
tetramers, it should be noticed, that in eukarya most of the
guide H/ACA snoRNAs contain two stem–loop structures
with a pseudouridylation pocket. As they both have to be
associated with a CBF5–NOP10 complex, one may imagine
a synergistic binding of the two complexes by heterotetramer
formation. Although the presence of two stem–loop structures
is not a general rule in archaeal H/ACA sRNAs, some of these
sRNAs also have two stem–loop structures [(41) and
S. Muller, F. Leclerc and C. Branlant, unpublished data].
Conservation of aCBF5 and aNOP10 in eukarya
The present data are important for the understanding of the
structure of eukaryal H/ACA snoRNPs and their mechanism
of action. Indeed, the archaeal and eukaryal CBF5 and NOP10
proteins are highly conserved in the two kingdoms of
life and, up to now, no reconstitution of active the H/ACA
snoRNP was achieved using puriﬁed recombinant proteins
and in vitro transcribed RNAs (46). This is essentially due
to the difﬁculty to produce the eukaryal proteins CBF5 and
GAR1 of H/ACA snoRNP complexes in a soluble form. Such
difﬁculty also impairs their crystallization and 3D structure
determination. However, based on the present data, one
may model the 3D structure of the eukaryal CBF5–NOP10
Nucleic Acids Research, 2006, Vol. 34, No. 3 837complex. Interestingly, a linked has been established between
a genetic disease, designated as X-linked dyskeratosis
congenita (DC), and mutations found in the Dyskerin gene
(47). The most frequent mutations (48) are located in the PUA
domain and the N-terminal extension that wraps the PUA
domain. In agreement with the present data, this strengthens
the importance of this domain in H/ACA snoRNP assembly.
In vertebrates, in addition to snoRNAs and scaRNAs (49),
the telomeric RNA also contains an H/ACA domain that
binds the complete set of NHP2, CBF5/Dyskerin, NOP0
and GAR1 proteins from H/ACA snoRNPs (50,51). Patients
suffering from DC were found to have a decreased level of
telomerase (52). We are presently generating the most pre-
valent mutations found in the Dyskerin encoding gene into
the aCBF5 gene in order to test for their effects on aCBF5
binding to the sRNA, sRNP assembly and sRNP activity.
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